新型可入脑的PD-L1小分子抑制剂的发现与表征 Poster number:B151 Session:Poster Session B Session date and time:Friday, October 13 | 12:30 pm-4:00 pm Session location:Level 2, Exhibit Hall D
Abbiskopresented the following posters at the ENA conference: Title:Discovery and characterization of an MTA-cooperative and brain-penetrant PRMT5 inhibitor Posternumber:C130 Session date and time:Saturday, October 14 | 12:30 pm-4:00 pm Session location:Level 2, Exhibit Hall D Background: MTAP ...
Circle Pharma, a biopharmaceutical company advancing the discovery and development of intrinsically cell-permeable macrocycles, today announced an upcoming poster presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and C...
Sep 20,2023 By Abbisko Back Abstract title:Discovery and characterization of an MTA-cooperative and brain-penetrant PRMT5 inhibitor Poster number:C130 Session:Poster Session C Session date and time:Saturday, October 14 | 12:30 pm-4:00 pm ...
The“full access”virtual Symposium registration includes access to all live broadcast scientific sessions including the Opening Ceremony and on-demand sessions, along with the virtual exhibition and online poster areas. It also includes exclusive access to the webcasts for 3 months after the Symposiu...
--Purple Biotech Ltd., a clinical-stage company developing first-in-class therapies that overcome tumor immune evasion and drug resistance, today announced it has been selected for a poster presentation at the 36 th European Organization for Research and
The Company also provided two poster presentations at the conference. The Selective SMARCA2 Degrader, PRT3789, Counteracts the Protective Cellular Stress Response to Chemotherapy and Enhances the Efficacy of Standard of Care Chemotherapeutic Agents in SMARCA4 Mutant NSCLC Models ...